Medistim ASA (0OCD) Income Statement
Medistim ASA Income Statement
Last quarter (Q3 2026), Medistim ASA's total revenue was $209.99M, an increase of 25.85% from the same quarter last year. In Q3, Medistim ASA's net income was $47.80M. See Medistim ASA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 699.77M | $ 562.60M | $ 521.11M | $ 486.26M | $ 417.82M | |
| $ 321.19M | $ 448.92M | $ 408.83M | $ 379.78M | $ 320.70M | |
| $ 375.40M | $ 311.41M | $ 277.39M | $ 238.53M | $ 204.43M | |
| Depreciation and Amortization | $ 22.69M | $ 24.51M | $ 23.66M | $ 23.29M | $ 23.43M |
| $ 235.77M | $ 155.59M | $ 155.10M | $ 169.72M | $ 138.09M | |
| $ 196.20M | $ 131.08M | $ 131.44M | $ 141.25M | $ 116.28M | |
| $ 10.65M | $ 3.17M | $ 3.77M | $ 4.80M | $ -2.21M | |
| $ 206.85M | $ 134.25M | $ 135.21M | $ 146.05M | $ 114.07M | |
| $ 159.21M | $ 103.83M | $ 103.82M | $ 113.97M | $ 90.90M | |
| Per Share Metrics | |||||
| Basic EPS | $ 8.71 | $ 5.67 | $ 5.67 | $ 6.25 | $ 4.99 |
| Diluted EPS | $ 8.71 | $ 5.67 | $ 5.67 | $ 6.24 | $ 4.98 |
| Weighted Average Shares Outstanding | 18.28M | 18.31M | 18.30M | 18.25M | 18.22M |
| Weighted Average Shares Outstanding (Diluted) | 18.28M | 18.31M | 18.30M | 18.28M | 18.25M |
Currency in NOK
